Camlin Fine Sciences Ltd

BSE: CAMLINFINE532834ISIN INE052I01032

Commodities
Specialty Chemicals
BSE 1000

Share price

₹74.13-16.99 (-18.65%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded. Earlier history is omitted pending corporate-action verification.

52W high: ₹202.55
52W low: ₹73.50
Off 52W high: -63.40%
1M return: -18.75%
3M return: -42.82%
6M return: -45.53%
1Y return: -62.26%
20D avg volume: 87,004
50 DMA: ₹94.80
200 DMA: ₹121.12

Key ratios Consolidated

Market cap: ₹1,424 Cr
Current price: ₹74.13
52W high / low: ₹202.55 / ₹73.50
Face value: ₹1.00
P/E: -100.65
P/B: 1.47
EPS (TTM): ₹-0.74
Book value / share: ₹50.60
ROE: —
ROCE: 2.90%
Operating margin: —
Net margin: —
Debt / equity: 0.67
Net debt: ₹559.53 Cr
Interest cover: 0.54
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 78.7 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	491.46	519.88	424.81	457.20	459.83	423.55	437.46	433.49	422.97	395.85	401.69	385.89
	4.96	1.34	23.91	2.94	4.59	8.56	9.59	1.34	12.10	1.87	5.76	1.66
	496.42	521.22	448.72	460.13	464.42	432.12	447.06	434.83	435.07	397.72	407.46	387.55
	529.74	543.76	447.42	470.22	464.15	437.27	412.55	433.31	426.84	421.20	451.16	397.28
	264.20	312.35	120.73	267.66	209.02	225.85	194.87	173.26	223.06	214.54	136.68	156.19
	29.32	5.82	18.16	13.73	31.92	17.41	2.36	45.40	53.93	15.84	43.31	39.02
	72.27	73.43	65.93	63.76	60.29	59.57	50.13	51.96	52.27	51.18	46.17	45.49
	20.59	14.01	22.98	18.33	18.91	15.83	16.11	34.12	26.42	23.37	16.17	14.14
	19.92	19.16	20.82	16.73	18.83	16.92	18.39	14.48	20.69	20.11	20.05	20.58
	121.28	131.49	118.91	123.39	119.41	108.07	112.63	116.43	108.38	108.50	107.15	104.47
	-33.32	-22.55	1.30	-10.09	0.27	-5.16	34.50	1.52	8.23	-23.48	-43.70	-9.73
	-1.93	-11.11	-7.95	-17.51	0.00	0.00	-5.59	0.00	-151.04	0.00	-49.80	0.00
	-35.25	-33.66	-6.65	-27.60	0.27	-5.15	28.91	1.52	-142.81	-23.48	-93.51	-9.73
	-6.81	0.46	-6.24	0.05	5.91	-0.01	7.95	7.14	26.20	11.17	11.72	4.55
	-29.70	-33.62	86.28	-37.10	-14.95	-10.68	0.11	-7.47	-116.11	-34.65	-81.78	-14.28
	-1.45	-1.65	4.59	-1.91	-0.76	-0.53	1.17	-0.24	-5.98	-2.03	-4.64	-0.71
Key metrics
	5.26	-0.49	37.15	7.46	38.01	27.60	63.41	50.12	-95.70	20.00	-57.29	24.99
	1.10%	-0.10%	8.70%	1.60%	8.30%	6.50%	14.50%	11.60%	-22.60%	5.10%	-14.30%	6.50%
	-6.00%	-6.50%	20.30%	-8.10%	-3.30%	-2.50%	0.00%	-1.70%	-27.50%	-8.80%	-20.40%	-3.70%
	-1.20%	—	1.20%	—	1.60%	—	3.80%	—	—	—	—	—
	6.90%	22.70%	-2.90%	5.50%	8.70%	7.00%	8.90%	12.30%	—	—	—	—
	-98.70%	-214.80%	78,336.40%	-396.70%	87.10%	69.20%	100.10%	47.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,893	1,723	1,667	1,613	1,682	1,412
	33.15	28.79	14.45	15.56	5.80	33.03
	1,926	1,752	1,681	1,629	1,687	1,445
	1,991	1,760	1,622	1,678	1,597	1,351
	964.94	823.27	786.26	746.62	855.57	727.60
	67.03	88.60	117.53	114.26	60.71	45.30
	275.39	243.90	192.29	178.75	162.62	145.05
	75.91	72.94	99.88	60.30	58.51	35.77
	76.63	70.92	63.84	78.61	62.51	55.97
	495.07	450.08	416.87	446.78	500.44	354.74
	-64.66	-8.19	58.84	-49.44	90.06	94.11
	-38.50	-25.46	-9.82	-49.80	-9.68	0.00
	-103.16	-33.65	49.03	-99.24	80.38	94.11
	-12.54	0.46	0.07	5.63	40.57	33.61
	-14.14	23.54	-158.12	-104.88	39.81	60.37
	-0.42	-1.59	-8.03	-5.58	3.45	4.65
Key metrics
	49.38	110.21	212.75	39.67	201.40	185.85
	2.61%	6.40%	12.80%	2.50%	12.00%	13.20%
	-0.75%	1.40%	-9.50%	-6.50%	2.40%	4.30%
	—	2.90%	12.60%	—	—	—
	7.92%	3.40%	3.30%	-4.10%	19.10%	—
	—	114.90%	-50.80%	-363.50%	-34.10%	—
	—	24.50	-15.73	—	—	—
	—	3.49	-0.17	—	—	—
	—	0.67	0.74	—	—	—
	—	559.53	541.57	—	—	—
	—	78.7	104.7	—	—	—
Balance sheet
	—	2,324	2,024	—	—	—
	—	1,234	1,183	—	—	—
	—	108.56	104.07	—	—	—
	—	373.02	328.22	—	—	—
	—	503.74	526.86	—	—	—
	—	146.52	124.12	—	—	—
	—	625.09	592.56	—	—	—
	—	505.19	377.22	—	—	—
	—	974.42	846.21	—	—	—
	—	668.09	645.64	—	—	—
	—	365.48	377.34	—	—	—
	—	302.61	268.30	—	—	—
	—	1,001	874.78	—	—	—
Cash flow
	—	82.07	26.72	—	—	—
	—	-52.95	-75.35	—	—	—
	—	-24.63	72.44	—	—	—
	—	57.57	42.45	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	244.58	222.49	183.52	218.92	244.04	191.44	272.60	205.07	226.91	181.91	220.33	185.61
	4.54	1.40	15.30	5.77	10.19	3.69	8.94	6.82	3.08	1.78	5.55	2.13
	249.12	223.89	198.82	224.69	254.24	195.13	281.53	211.89	229.99	183.69	225.88	187.73
	280.29	242.56	212.84	228.30	258.05	211.50	269.90	219.08	244.26	201.29	272.63	205.42
	163.44	145.60	77.68	110.68	114.40	99.06	150.03	106.45	151.05	131.70	108.32	103.72
	3.75	1.49	2.04	0.81	0.37	0.47	0.58	0.48	13.63	2.26	3.88	1.02
	20.42	20.28	18.07	19.93	19.36	18.62	18.89	17.18	19.60	16.81	16.54	16.23
	15.49	13.38	22.05	14.86	18.73	11.34	17.44	17.15	17.92	13.62	13.88	13.30
	13.79	13.51	13.28	13.51	13.47	13.40	13.13	13.26	13.44	12.69	12.78	12.40
	62.34	62.44	62.91	67.22	72.35	65.65	73.09	70.20	62.69	56.17	64.42	55.88
	-31.17	-18.67	-14.03	-3.61	-3.81	-16.38	11.63	-7.20	-14.27	-17.60	-46.75	-17.69
	0.00	0.00	-2.61	-13.66	0.00	0.00	0.27	—	-96.27	—	-1.93	—
	-31.17	-18.67	-16.64	-17.27	-3.81	-16.38	11.90	-7.20	-110.54	-17.60	-48.68	-17.69
	-11.16	-6.36	-10.99	-4.27	-0.17	5.70	-3.72	1.57	37.91	3.92	4.61	6.05
	-20.01	-12.31	-5.65	-13.00	-3.64	-10.68	15.62	-5.63	-72.62	-13.68	-44.07	-11.64
	-1.04	-0.64	-0.29	-0.69	-0.19	-0.57	0.86	-0.33	-4.34	-0.82	-2.65	-0.70
Key metrics
	-1.89	8.22	18.69	11.10	28.39	8.36	42.47	23.21	-79.18	8.71	-22.02	8.01
	-0.80%	3.70%	10.20%	5.10%	11.60%	4.40%	15.60%	11.30%	-34.90%	4.80%	-10.00%	4.30%
	-8.20%	-5.50%	-3.10%	-5.90%	-1.50%	-5.60%	5.70%	-2.70%	-32.00%	-7.50%	-20.00%	-6.30%
	-1.40%	—	0.50%	—	1.40%	—	2.80%	—	—	—	—	—
	0.20%	16.20%	-32.70%	6.80%	7.50%	5.20%	23.70%	10.50%	—	—	—	—
	-449.70%	-15.30%	-136.20%	-130.90%	95.00%	21.90%	135.40%	51.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	869.51	837.92	886.49	773.26	789.44	685.51
	27.01	34.95	20.62	18.88	28.83	18.70
	896.52	872.87	907.11	792.14	818.27	704.21
	963.99	910.69	934.53	849.85	751.64	668.13
	497.40	401.82	539.22	426.29	402.75	382.17
	8.09	3.69	16.95	8.46	5.54	7.62
	78.70	75.98	72.48	65.95	59.71	52.89
	65.78	66.99	66.12	54.33	56.94	33.43
	54.09	53.68	52.53	49.39	32.82	26.68
	254.91	268.13	262.14	236.52	236.47	160.63
	-67.48	-37.82	-27.43	-57.70	66.63	36.08
	-16.27	-16.27	-96.00	-1.93	—	—
	-83.75	-54.09	-123.43	-59.63	66.63	36.08
	-32.78	-21.13	47.12	8.24	19.07	10.21
	-50.97	-32.97	-76.31	-51.39	47.55	25.87
	-2.66	-1.74	-4.41	-3.09	3.18	1.98
Key metrics
	36.12	66.58	-4.78	44.09	156.39	96.19
	4.15%	7.90%	-0.50%	5.70%	19.80%	14.00%
	-5.86%	-3.90%	-8.60%	-6.60%	6.00%	3.80%
	—	1.10%	-5.50%	—	—	—
	-4.78%	-5.50%	14.60%	-2.00%	15.20%	—
	—	56.80%	-48.50%	-208.10%	83.80%	—
	—	16.38	-0.77	—	—	—
	—	-1.33	-0.29	—	—	—
	—	0.51	0.51	—	—	—
	—	435.56	405.75	—	—	—
	—	175.1	168.8	—	—	—
Balance sheet
	—	1,772	1,629	—	—	—
	—	919.27	929.38	—	—	—
	—	36.22	36.07	—	—	—
	—	474.10	414.48	—	—	—
	—	243.51	263.16	—	—	—
	—	29.31	37.11	—	—	—
	—	513.98	520.31	—	—	—
	—	315.65	267.86	—	—	—
	—	621.36	579.52	—	—	—
	—	471.78	441.82	—	—	—
	—	261.40	269.96	—	—	—
	—	210.38	171.86	—	—	—
	—	928.83	862.27	—	—	—
Cash flow
	—	43.96	21.86	—	—	—
	—	-30.40	-87.66	—	—	—
	—	-13.41	101.19	—	—	—
	—	27.58	22.63	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +2.01%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -4.78%
Profit YoY (TTM): -1,077.14%

Consolidated

Sales CAGR 3Y: +0.82%
Sales CAGR 5Y: —
Profit CAGR 3Y: -16.07%
Profit CAGR 5Y: —
Sales YoY (TTM): +7.92%
Profit YoY (TTM): +57.14%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 48.03%

Quarter	September 2026	June 2026
Promoter %	48.03%	48.03%

Holder	Type	Holding	Previous	Change
Ashish Subhash Dandekar	Promoter	10.30%	10.30%	0.00%
Infinity Direct Holdings	Promoter	10.18%	10.18%	0.00%
Anfima Nv	Promoter	8.83%	8.83%	0.00%
Infinity Holdings	Promoter	6.20%	6.20%	0.00%
Icici Prudential Commodities Fund	Public	4.97%	4.77%	+0.20%
Infinity Direct Capital	Promoter	4.82%	4.82%	0.00%
Camart Finance Limited	Promoter	2.77%	2.77%	0.00%
Nirmal Vinod Momaya	Public	1.88%	1.88%	0.00%
Anagha Subhash Dandekar	Promoter	1.57%	1.57%	0.00%
Ajay Upadhyaya	Public	1.38%	1.30%	+0.08%
Vibha Agencies Pvt Ltd	Promoter	1.36%	1.36%	0.00%
Infinity Portfolio Holdings	Promoter	1.17%	1.17%	0.00%
Jagdish N Master	Public	1.02%	1.01%	+0.01%
Cafco Consultants Limited	Promoter	0.78%	0.78%	0.00%
Radha Pandit	Promoter Group	0.04%	0.04%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Pidilite Industries Ltd.	1,53,494	1,507.00	56.47	28.50%	+16.83% TTM	+20.94% TTM	+3.57%
Gujarat Fluorochemicals Limited	50,673	4,612.90	75.63	10.10%	+20.33% TTM	-1.47% TTM	+25.63%
Navin Fluorine International Limited	45,075	8,785.00	49.50	18.70%	+45.68% TTM	+105.04% TTM	+45.12%
Deepak Nitrite Limited	21,559	1,580.65	20.29	10.80%	+23.80% TTM	+99.83% TTM	-9.73%
Aether Industries Limited	20,478	1,542.85	82.16	12.20%	+30.76% TTM	+28.03% TTM	+103.85%
Aarti Industries Ltd	16,311	449.65	27.46	8.50%	+39.85% TTM	+104.40% TTM	+16.66%
Fine Organic Industries Limited	15,720	5,127.35	38.71	20.20%	+12.92% TTM	+18.80% TTM	+16.19%
Atul Limited.	15,177	5,155.00	19.28	13.50%	+18.15% TTM	+40.10% TTM	-12.49%
Anupam Rasayan India Limited	13,029	1,144.40	57.92	7.50%	+51.76% TTM	+14.65% TTM	+6.58%
PRIVI SPECIALITY CHEMICALS LIMITED	12,825	3,283.30	34.73	25.10%	+17.54% TTM	+44.15% TTM	+10.09%
BASF India Ltd	12,812	2,959.95	21.44	13.10%	+13.35% TTM	+59.30% TTM	-33.46%
Sudeep Pharma Limited	12,657	1,120.60	67.10	24.20%	—	—	—
Vinati Organics Ltd.	10,334	996.85	25.09	17.70%	+10.98% TTM	-5.48% TTM	-39.90%
Elantas Beck India Ltd S	10,127	12,774.65	54.20	—	+18.86% TTM	+35.25% TTM	+29.29%
Jubilant Ingrevia Limited	8,957	562.35	25.55	10.80%	+15.41% TTM	+21.73% TTM	-18.43%
Alkyl Amines Chemicals Ltd. S	8,108	1,585.25	32.77	14.60%	+13.38% TTM	+35.83% TTM	-13.31%
Galaxy Surfactants Limited	8,048	2,269.80	22.75	12.70%	+27.05% TTM	+16.13% TTM	+0.01%
Clean Science and Technology Limited	6,979	656.60	29.92	19.20%	+4.51% TTM	-12.06% TTM	-33.34%
Neogen Chemicals Limited	6,815	2,268.40	168.60	6.80%	+26.66% TTM	+55.16% TTM	+54.05%
Fineotex Chemical Limited	6,221	53.42	41.98	16.20%	+91.44% TTM	+41.07% TTM	+84.27%
Balaji Amines Ltd.	5,738	1,770.80	23.80	10.20%	+20.91% TTM	+66.05% TTM	+26.00%
Archean Chemical Industries Limited	5,291	428.60	54.04	7.80%	+5.99% TTM	-42.66% TTM	-34.05%
Prasol Chemicals Limited	4,594	776.20	—	—	—	—	—
Laxmi Organic Industries Limited	4,501	161.95	35.81	4.40%	+5.47% TTM	+25.01% TTM	-17.12%
Foseco India Ltd S	4,494	5,962.25	57.00	—	+10.33% TTM	-3.71% TTM	+5.42%
Camlin Fine Sciences Ltd	1,424	74.13	-100.65	2.90%	+7.92% TTM	+57.14% TTM	-62.26%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Newspaper Publication - UFR for the quarter and half year ended September 30, 2026.4 Nov 2026 · Company Update / Newspaper Publication
Audio Recording of the Investor Call - Q2 & H1FY273 Nov 2026 · Company Update / Analyst / Investor Meet
Investor Presentation - Q2 & H1FY273 Nov 2026 · Company Update / Investor Presentation
Outcome of Board Meeting dated November 3, 20263 Nov 2026 · Board Meeting / Outcome of Board Meeting
Un-audited Financial Results for the quarter and half year ended September 30, 20263 Nov 2026 · Result / Financial Results
Enclosed30 Oct 2026 · Company Update / General
Schedule of Investor Meet29 Oct 2026 · Company Update / Analyst / Investor Meet
Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the un-audited Standalone ....29 Oct 2026 · Board Meeting / Board Meeting
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 29, 2026 for Ashish Subhash Dandekar29 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Intimation of completion of tenure of Independent Director of the Company.18 Oct 2026 · Company Update / Change in Management
Scrutinizers Report with Voting Results16 Oct 2026 · AGM/EGM / Postal Ballot
Outcome of Postal Ballot16 Oct 2026 · AGM/EGM / Postal Ballot
Allotment of ESOP16 Oct 2026 · Company Update / Allotment of ESOP / ESPS
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.6 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of trading window24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication - Dispatch of Notice of Postal Ballot16 Sep 2026 · Company Update / Newspaper Publication
Postal Ballot Notice15 Sep 2026 · AGM/EGM / Postal Ballot
Appointment of Additional Non-executive Independent Director of the Company.9 Sep 2026 · Company Update / Change in Management
Transcript of the Earnings Call Q1FY2717 Aug 2026 · Company Update / Earnings Call Transcript
Newspaper Publication - Unaudited Financial Results for the quarter ended June 30, 2026.12 Aug 2026 · Company Update / Newspaper Publication
Investor Call Recording Q1 FY2711 Aug 2026 · Company Update / Analyst / Investor Meet
Investor Presentation Q1 FY2711 Aug 2026 · Company Update / Investor Presentation
Outcome of Board Meeting dated August 11, 202611 Aug 2026 · Board Meeting / Outcome of Board Meeting
Un-audited Financial Results for the quarter ended June 30, 202611 Aug 2026 · Result / Financial Results
Scrutinizers Report with Voting Results of 33rd AGM11 Aug 2026 · AGM/EGM / AGM
Proceedings of the 33rd AGM11 Aug 2026 · AGM/EGM / AGM
Schedule of Investor Meet - Q1FY27 Earnings Call4 Aug 2026 · Company Update / Analyst / Investor Meet
Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....4 Aug 2026 · Board Meeting / Board Meeting
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 28, 2026 for Ashish Subhash Dandekar28 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Newspaper Publication - Dispatch of Notice of 33rd Annual General Meeting of the Company.19 Jul 2026 · Company Update / Newspaper Publication
Enclosed.18 Jul 2026 · Company Update / General
BRSR for the FY 2025-26.18 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Enclosed.18 Jul 2026 · AGM/EGM / AGM
Annual Report for the FY 2025-26.18 Jul 2026 · Others / Reg. 34 (1) Annual Report
Newspaper Publication pursuant to 33rd Annual General Meeting of the Company.15 Jul 2026 · Company Update / Newspaper Publication
Enclosed9 Jul 2026 · Company Update / General
Certificate under Re. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.8 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Resignation of Senior Management Personnel of the Company.7 Jul 2026 · Company Update / Change in Management
Enclosed.1 Jul 2026 · Company Update / General
Intimation of Schedule of Investor meet28 Jun 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Right Issue of Equity Shares	8 Jan 2025	8 Jan 2025	—

Board meetings

3 Nov 2026 Board Meeting - Financial Results
11 Aug 2026 Board Meeting - Financial Results